
Keywords: سکته قلبی; Novel oral antiplatelet; NOAP; prasugrel; ticagrelorADP, Adenosine diphosphate; CASP, Critical Appraisal Skills Programme; FDA, Food and Drug Administration; MI, Myocardial infarction; NOAP, Novel oral antiplatelet; SDCEP, Scottish Dental Clinical Effecti